/C O R R E C T I O N -- Human Longevity, Inc./
In the news release, Human Longevity, Inc. Expands Pancreatic Cancer Prevention Commitment with $1 Million Pledge for Qualified Members, issued 17-Jun-2025 by Human Longevity, Inc. over PR Newswire, we are advised by the company that the media contact information should be added to the public distribution. The complete, corrected release follows:
SOUTH SAN FRANCISCO, Calif., June 17, 2025 /PRNewswire/ -- Human Longevity, Inc. (HLI), a global leader in precision medicine and proactive health, today announced an expansion of its $1 million pledge initiative—this time targeting late-stage pancreatic cancer. Building on the success of its recent prostate cancer commitment, HLI is advancing its mission to detect cancer earlier and improve outcomes for its members by offering financial and clinical support for those members diagnosed with late-stage pancreatic cancer while enrolled in its Executive Health and 100+ Longevity programs.
Driving Innovation in Early Detection
Through its Executive Health Program and 100+ Longevity Programs, Human Longevity has delivered care to over 10,000 members using a comprehensive platform that integrates whole genome sequencing, advanced imaging, and multiplex blood biomarker tracking.
These efforts have enabled the development of what HLI believes to be one of the most advanced early detection algorithms for pancreatic cancer available today, including a new proprietary DNA-based pancreatic cancer screening test.
In most cases, our multi-modal screening approach helps detect cancer at a stage when it is curable. But in the rare event that a member is diagnosed at a late stage, our $1 million pledge ensures they receive the most advanced care available—without the burden of financial barriers.
How the $1 Million Pledge Works
Eligible individuals must be active pledge participants in HLI's Executive Health Program or affiliated Longevity Programs for pancreatic cancer early screening. These programs include:
Whole genome sequencing
Whole-body MRI, with dedicated pancreatic imaging
Long-term blood biomarker analysis
A DNA-based pancreatic cancer screening blood test
Qualified members diagnosed with late-stage pancreatic cancer while under HLI's care will receive up to $1 million toward treatment, care coordination, and access to a network of top-tier oncology experts from leading medical institutions.
Transforming the Future of Pancreatic Cancer Care
Pancreatic cancer is one of the deadliest forms of cancer due to its lack of early symptoms and late detection. Human Longevity's initiative aims to shift this paradigm by detecting disease earlier—when it is most treatable. The pledge not only offers support to individuals but also accelerates advancements in cancer screening technology through continuous real-world data integration and machine learning.
About Human Longevity, Inc.
Human Longevity, Inc. is a pioneering biotechnology company at the forefront of genomics, AI, and advanced medical technologies to extend healthspan and revolutionize preventative care. By leveraging vast genomic data, metabolomics, advanced imaging, and AI-driven diagnostics, Human Longevity is transforming healthcare from disease management to proactive prevention through its Executive Health and other Longevity Programs. The company remains committed to advancing medical research, improving patient outcomes, and unlocking the full potential of genomics to address the world's most pressing health challenges.
Media Contactmedia@humanlongevity.com
https://www.humanlongevity.com/1mpancreatic/
View original content to download multimedia:https://www.prnewswire.com/news-releases/human-longevity-inc-expands-pancreatic-cancer-prevention-commitment-with-1-million-pledge-for-qualified-members-302483622.html
SOURCE Human Longevity, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Jackson County short-term rental owners concerned ahead of World Cup 2026
KANSAS CITY, Mo. – A change in property classifications has short-term rental owners in Jackson County concerned. This comes as Kansas City's first World Cup 2026 match is scheduled for one year from Monday. Ribbon cutting to take place for Margaritaville Hotel Kansas City Short-term rental owners, including those who operate Airbnbs and VRBOs (Vacation Rentals by Owner) are concerned this might affect lodging options for soccer fans, and thereby, owners' chances to make money. Some rental owners complain they learned of the change in classification when their new Jackson County tax assessments arrived in the mail. In some cases, property taxes on their properties jumped by 200-300 percent. Its causing some to question the big increases they'll have to pay, after their properties are changed from residential to commercial. 'It's taxation without representation,' Laura Williams, who operates a Waldo-based short-term rental property, said on Monday. 'We were never given a notice. All we got was this piece of paper right here,' Williams said, while sharing her new tax assessment paperwork on the Waldo property. Williams showed FOX4 her annual taxes more than tripled to $6,872. That's on top of the short-term rental taxes and registration she already pays to Kansas City, Missouri. 'Who is going to want to rent out their house for the World Cup when it's going to cause their property taxes to triple?' Williams asked. 'I think it's something people in Kansas City should be concerned about.' On Monday afternoon, a spokesperson for Jackson County said this reclassification is the result of a change in state law that defines properties that are available for rental periods of less that 30 days as 'transient housing', which means they don't qualify as residential. Jackson County Tax Assessor Gail McCann Beatty addressed this change with county leaders in late May. However, no one would answer specific questions from FOX4 about local effects of the change on Monday. Jackson County Sixth District Legislator Sean Smith said he believes this change from Jackson County may be unconstitutional, and that the assessor's office didn't inform the public about upcoming changes in their taxes. Smith wants to know if this affects all short-term rental operators, including those who register their properties as an option of renting them. 'The implementation and execution have been very poor. It should have been talked about in the public, so that if somebody is on the registry, but they have no way of using it, they could have made an informed decision,' Smith said. Download WDAF+ for Roku, Fire TV, Apple TV Smith also believes this increase in tax assessment is being applied to short-term rentals in Kansas City, Missouri only, and not in other Jackson County cities. He said he intends to address these concerns at a Wednesday morning legislative meeting. Smith has produced . Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Business Wire
3 hours ago
- Business Wire
Align Technology Launches Integrated Consumer and Professional Brand Campaign Focused on Invisalign ® Treatment for Kids and Teens
TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. ('Align') (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign ® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced integrated global professional and consumer campaigns to highlight the unique needs of growing patients and treatment options for meeting those needs and creating new smiles with the Invisalign clear aligner system. As the leader in digital orthodontics, Align has developed an extensive end-to-end portfolio that helps doctors treat a range of case types including the most complex cases, and growing patients and kids as young as 6. Share 'We are proud to launch these complementary Invisalign ® brand campaigns about the kid and teen-friendly orthodontic solutions from the #1 doctor-recommended clear aligner brand, 1 ' said Kamal Bhandal, senior vice president, Global Brand, Consumer and Americas Marketing. 'Our new 'Invisalign for Kids' brand consumer campaign is designed to increase awareness with parents that Invisalign aligners are an effective solution for kids and educate parents about the benefits of Invisalign treatment for kids and teens, including Invisalign ® Palatal Expander System, Invisalign First™, Invisalign ® System with mandibular advancement, as well as Invisalign ® Virtual Care to help parents monitor progress – all designed to deliver predictable results and a positive experience for growing children.' The aspects of Invisalign treatment, from Phase 1 to comprehensive Phase 2, to retention are designed for predictable results and a positive experience while addressing the unique needs of growing children. And with Invisalign aligners, children can enjoy their favorite foods, keep up their oral hygiene, maintain an active lifestyle, and smile and build their confidence. At the same time, our companion Invisalign 'Growing Patients' professional campaign provides doctors with information and awareness about the dedicated range of Invisalign treatment options designed specifically for children and teens from well-established products such as Invisalign First™ aligners to the latest additions in the growing patient product portfolio, including the Invisalign ® Palatal Expander System and Invisalign ® System with mandibular advancement featuring occlusal blocks ('MAOB'). Doctors can use the Invisalign System to treat nearly any orthodontic case, from children through teens to adults, at the different stages of their growth. Even with some baby teeth, it may be the perfect time for children ages 6 to 10 to start Phase 1 orthodontic treatment. According to the American Association of Orthodontists ('AAO'), children should get screened by an orthodontist by age 7. 2 Phase 1 treatment takes advantage of a child's normal development to help bones in the face and mouth grow correctly and reduce the need for more extensive treatment later. Once most permanent teeth are in place, Phase 2 treatment focuses on ensuring teeth are in their proper place for a healthy bite and a pleasing appearance. 3 'As kids and teens age and grow, orthodontic treatment needs to address both tooth movement and dental facial orthopedic or skeletal movement,' said Dr. Mitra Derakhshan, executive vice president, chief clinical officer, Global Treatment Planning and Clinical Services. 'As the leader in digital orthodontics, Align has developed an extensive end-to-end portfolio that helps doctors treat a range of case types including the most complex cases, and growing patients and kids as young as 6. I believe our new 'Invisalign for Kids' brand and 'Growing Patients' campaigns will help increase confidence in Invisalign treatment for the largest segment of the orthodontic market and drive further adoption among growing patients.' This latest announcement is part of Align's long-term investment in the growing patients' segment of the market which has included multiple innovation milestones over 20 million smiles. Overview of Invisalign products for growing patients: 2008: Invisalign ® Teen – Teen specific features to address patient compliance, natural eruption of permanent teeth, and root-movement control – issues that are common in treatment of younger patients. 2017: Invisalign ® System with mandibular advancement – the first clear aligner solution designed for simultaneous Class II correction and alignment in growing tween and teen patients and Invisalign ® System with mandibular advancement featuring enhanced precision wings. 2018: Invisalign First™ – the first clear aligner treatment with features designed specifically to address a broad range of indications in mixed-dentition patients, including shorter clinical crowns, management of erupting dentition, and predictable dental arch expansion. 2023: Invisalign ® Palatal Expander System –Align's first direct 3D printed orthodontic device, provides a safe, comfortable, and clinically effective 4 alternative to traditional palatal expanders that require manually turning a screw in the device in the mouth daily to achieve skeletal expansion. 2025: Invisalign ® System with mandibular advancement featuring occlusal blocks – Align's first clear aligner product with integrated solid occlusal blocks that delivers predictable mandibular advancement. Invisalign occlusal blocks provide durability, improve engagement, and enable vertical opening to offer earlier advancement of the mandible in cases like Class II deep bite to improve treatment efficiency. 'Our commitment is to support our doctors in treating patients through every step of their journey – from first visit to a lasting smile. More than 28 years of anonymized data from more than 20 million Invisalign ® patients treated globally have helped Align develop our integrated suite of innovative products and solutions that enable doctors to treat patients over their continuum of care,' said Michael Smith, Align vice president, Product Management. 'This new integrated campaign highlights the unique product offerings within our growing patient portfolio and how we are innovating in digital orthodontics to empower doctors to transform smiles and change lives.' 1. Based on a global survey of 1,786 doctors (dentists and orthodontists who use clear aligners) by IQVIA in NA, EMEA, LATAM, and APAC. Data on File at Align Technology, as of June 30, 2022. 2. American Academy of Orthodontists. The Right Time: When Should Your Child See an Orthodontist? ( Accessed 2/26/24. 3. American Academy of Orthodontists. Embarking on a Two Phase Orthodontic Adventure ( Accessed 2/28/24. 4. Based on a survey in August 2023 in Canada of 10 Invisalign trained orthodontists who participated in the Invisalign Palatal Expander System Technical Design Assessment and have treated at least 1 patient age 6-11 years with IPE. Data on file at Align Technology, Inc. as of October 30, 2023. About Align Technology, Inc. Align Technology designs and manufactures the Invisalign ® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 281.4 thousand doctor customers and are key to accessing Align's 600 million consumer market opportunity worldwide. Over the past 28 years, Align has helped doctors treat over 20.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align™ Digital Platform, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit for more information. For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit For additional information about the iTero digital scanning system, please visit For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit Invisalign, iTero, exocad, Align, Align Digital Platform and iTero Lumina are trademarks of Align Technology, Inc.
Yahoo
4 hours ago
- Yahoo
MGIC Investment Corporation (MTG) Hits Fresh High: Is There Still Room to Run?
Shares of MGIC Investment (MTG) have been strong performers lately, with the stock up 0.2% over the past month. The stock hit a new 52-week high of $27.34 in the previous session. The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of the last four quarters. In its last earnings report on April 30, 2025, MGIC reported EPS of $0.75 versus consensus estimate of $0.66. For the current fiscal year, MGIC is expected to post earnings of $2.90 per share on $1.24 billion in revenues. This represents a -0.34% change in EPS on a 1.82% change in revenues. For the next fiscal year, the company is expected to earn $3.05 per share on $1.28 billion in revenues. This represents a year-over-year change of 5.06% and 2.93%, respectively. MGIC may be at a 52-week high right now, but what might the future hold for the stock? A key aspect of this question is taking a look at valuation metrics in order to determine if the company is due for a pullback from this level. On this front, we can look at the Zacks Style Scores, as these give investors a variety of ways to comb through stocks (beyond looking at the Zacks Rank of a security). These styles are represented by grades running from A to F in the categories of Value, Growth, and Momentum, while there is a combined VGM Score as well. The idea behind the style scores is to help investors pick the most appropriate Zacks Rank stocks based on their individual investment style. MGIC has a Value Score of C. The stock's Growth and Momentum Scores are C and C, respectively, giving the company a VGM Score of B. In terms of its value breakdown, the stock currently trades at 9.3X current fiscal year EPS estimates, which is not in-line with the peer industry average of 9.9X. On a trailing cash flow basis, the stock currently trades at 8.7X versus its peer group's average of 10.7X. Additionally, the stock has a PEG ratio of 2.48. This isn't enough to put the company in the top echelon of all stocks we cover from a value perspective. We also need to look at the Zacks Rank for the stock, as this supersedes any trend on the style score front. Fortunately, MGIC currently has a Zacks Rank of #1 (Strong Buy) thanks to favorable earnings estimate revisions from covering analysts. Since we recommend that investors select stocks carrying Zacks Rank of 1 (Strong Buy) or 2 (Buy) and Style Scores of A or B, it looks as if MGIC fits the bill. Thus, it seems as though MGIC shares could have potential in the weeks and months to come. Shares of MTG have been soaring, and the company still appears to be a decent choice, but what about the rest of the industry? One industry peer that looks good is EverQuote, Inc. (EVER). EVER has a Zacks Rank of # 1 (Strong Buy) and a Value Score of C, a Growth Score of A, and a Momentum Score of A. Earnings were strong last quarter. EverQuote, Inc. beat our consensus estimate by 18.75%, and for the current fiscal year, EVER is expected to post earnings of $1.17 per share on revenue of $644.08 million. Shares of EverQuote, Inc. have gained 0.3% over the past month, and currently trade at a forward P/E of 18.53X and a P/CF of 23.23X. The Insurance - Multi line industry is in the top 34% of all the industries we have in our universe, so it looks like there are some nice tailwinds for MTG and EVER, even beyond their own solid fundamental situation. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MGIC Investment Corporation (MTG) : Free Stock Analysis Report EverQuote, Inc. (EVER) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
